Skip to content

The effect of endurance, resistance and combination training on some inflammatory mediators in obese women

The effect of endurance, resistance and combined training (resistance-endurance) on the levels of Pentraxin 3, Galectin 3 and some inflammatory mediators in obese women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210626051720N1
Enrollment
48
Registered
2021-07-11
Start date
2021-07-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity.

Interventions

Intervention 1: Control group: 12 obese women without regular exercise. Intervention 2: Intervention group: Endurance exercise (performed by 12 obese women for 12 weeks and 3 sessions per week, 30 min

Sponsors

University of Tehran
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Overweight women with a body mass index above 30 No history of regular physical activity in the past year Having a general level of physical and mental health

Exclusion criteria

Exclusion criteria: Having type 2 diabetes Cardiovascular diseases Drug or alcohol addiction

Design outcomes

Primary

MeasureTime frame
Pentraxine 3. Timepoint: First, the end of the study. Method of measurement: Kit Eliza.;Galactin 3. Timepoint: First, the end of the study. Method of measurement: Kit Eliza.;Tumor necrosis factor-a (TNF-a). Timepoint: First, the end of the study. Method of measurement: Kit Eliza.;Serum Amyloid A (SAA). Timepoint: First, the end of the study. Method of measurement: Kit Eliza.

Secondary

MeasureTime frame
Insulin. Timepoint: First, the end of the study. Method of measurement: Insulin Eliza Kit.;Glucose. Timepoint: First, the end of the study. Method of measurement: Glucose Assessment Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKooti Mahrokh

The University of Tehran

kooti.mahrokh@gmail.com+98 21 2209 5009

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026